Načítá se...
Ruxolitinib for the Treatment of Patients With Polycythemia Vera
Polycythemia vera (PV) is a hematopoietic proliferative disorder associated with Janus-associated kinase (JAK)/signal transducer and activator of transcription (STAT) pathway dysregulation resulting in erythrocytosis and, possibly, leukocytosis and thrombocytosis. Patients diagnosed with PV experien...
Uloženo v:
| Vydáno v: | Expert Rev Hematol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4627585/ https://ncbi.nlm.nih.gov/pubmed/25980454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/17474086.2015.1045869 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|